Beate C. Litzenburger
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 9
- Cancer, Hypoxia, and Metabolism 4
- Oncology top 10%
- Cancer Cells and Metastasis 3
-
- Growth Hormone and Insulin-like Growth Factors 7
-
- Bioinformatics and Genomic Networks 3
-
- Genomics and Rare Diseases 3
- BRCA gene mutations in cancer 2
-
- Pain Mechanisms and Treatments 2
Beate C. Litzenburger
22 papers receiving 755 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 286
- Oncology 329
- Endocrinology, Diabetes and Metabolism 131
- Molecular Biology 421
- Pathology and Forensic Medicine 96
Countries citing papers authored by Beate C. Litzenburger
This map shows the geographic impact of Beate C. Litzenburger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beate C. Litzenburger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beate C. Litzenburger more than expected).
Fields of papers citing papers by Beate C. Litzenburger
This network shows the impact of papers produced by Beate C. Litzenburger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beate C. Litzenburger. The network helps show where Beate C. Litzenburger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Beate C. Litzenburger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 13 | |
| 2 | 2019 | 23 | |
| 3 | 2018 | 41 | |
| 4 | 2017 | 29 | |
| 5 | 2017 | 128 | |
| 6 | 2017 | 7 | |
| 7 | 2017 | 24 | |
| 8 | 2016 | 17 | |
| 9 | 2016 | 17 | |
| 10 | 2015 | 9 | |
| 11 | 2015 | 48 | |
| 12 | 2015 | 0 | |
| 13 | 2014 | 34 | |
| 14 | 2013 | 16 | |
| 15 | [Tapentadol prolonged release for the treatment of severe chronic tumor pain in routine clinical practice]. | 2012 | 5 |
| 16 | 2010 | 109 | |
| 17 | 2009 | 1 | |
| 18 | 2009 | 1 | |
| 19 | 2008 | 33 | |
| 20 | 2007 | 196 |
About Beate C. Litzenburger
Beate C. Litzenburger is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism and Oncology, having authored 23 papers that have together received 770 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Growth Hormone and Insulin-like Growth Factors (7 papers), Cancer, Hypoxia, and Metabolism (4 papers), Genomics and Rare Diseases (3 papers), Bioinformatics and Genomic Networks (3 papers), Cancer Cells and Metastasis (3 papers), Pain Mechanisms and Treatments (2 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Cancer Research (286 citations), Oncology (329 citations) and Endocrinology, Diabetes and Metabolism (131 citations). Beate C. Litzenburger has collaborated with scholars based in United States, Germany and Estonia. Frequent co-authors include Adrian V. Lee, Joan M. Carboni, Marco M. Gottardis, Michael T. Lewis, Vijaykumar Holla, Funda Meric‐Bernstam, Ann M. Bailey, Jia Zeng, Gordon B. Mills and Powel H. Brown. Their work appears in journals such as Journal of Clinical Oncology, Molecular and Cellular Biology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.